131 related articles for article (PubMed ID: 38186323)
1. A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters.
Murshidi R; Bani Hamad S; Al Refaei A; Shewaikani N; Shaf'ei M; Alshoubaki SN; Haddad TA; Khasawneh T; Fkheideh T; Abdallat M
J Dermatolog Treat; 2024 Dec; 35(1):2301435. PubMed ID: 38186323
[TBL] [Abstract][Full Text] [Related]
2. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris.
Cosansu NC; Yuksekal G; Turan U; Umitfer F; Yaldiz M; Sevimli Dikicier B
Cutan Ocul Toxicol; 2022 Jun; 41(2):174-178. PubMed ID: 35658795
[TBL] [Abstract][Full Text] [Related]
3. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
Öktem A; Hayran Y; Arı E; Yalçın B
J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
[No Abstract] [Full Text] [Related]
4. Laboratory Abnormalities in Acne Patients Treated With Oral Isotretinoin: A Retrospective Epidemiological Study.
Alajaji A; Alrawaf FA; Alosayli SI; Alqifari HN; Alhabdan BM; Alnasser MA
Cureus; 2021 Oct; 13(10):e19031. PubMed ID: 34853752
[TBL] [Abstract][Full Text] [Related]
5. Effect of isotretinoin treatment on inflammatory and hematological parameters in patients with acne vulgaris.
Esen M
Cutan Ocul Toxicol; 2024 Mar; 43(1):27-32. PubMed ID: 37837334
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
J Am Acad Dermatol; 2020 Jan; 82(1):72-79. PubMed ID: 31228528
[TBL] [Abstract][Full Text] [Related]
8. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
Zane LT; Leyden WA; Marqueling AL; Manos MM
Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin's Effect on Fasting Lipid Profile in Acne Patients.
Sajid M; Asim SA; Iqbal T; Bhatti S; Zahir A; Imtiaz S
J Coll Physicians Surg Pak; 2024 May; 34(5):518-521. PubMed ID: 38720209
[TBL] [Abstract][Full Text] [Related]
10. Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne.
Al-Haddab M; Alhuqayl A; Alsharif H; Alolyet D; Altaleb R
Cutis; 2021 Jul; 108(1):43-45. PubMed ID: 34397358
[TBL] [Abstract][Full Text] [Related]
11. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
[TBL] [Abstract][Full Text] [Related]
12. The utility of laboratory testing for pediatric patients undergoing isotretinoin treatment.
Parthasarathy V; Shah N; Kirkorian AY
Pediatr Dermatol; 2022 Sep; 39(5):731-733. PubMed ID: 35689471
[TBL] [Abstract][Full Text] [Related]
13. Abnormal liver function tests in acne patients receiving isotretinoin.
Pona A; Cardenas-de la Garza JA; Haidari W; Cline A; Feldman SR; Taylor SL
J Dermatolog Treat; 2021 Jun; 32(4):469-472. PubMed ID: 31498706
[TBL] [Abstract][Full Text] [Related]
14. A retrospective evaluation of laboratory parameters and hyperuricemia in patients with acne vulgaris under systemic isotretinoin treatment.
Sarac N; Pancar GS; Ozdemir S; Atilla S
J Dermatolog Treat; 2022 Mar; 33(2):1063-1066. PubMed ID: 32705916
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hematological parameters in patients using systemic isotretinoin with diagnosis of acne vulgaris.
Demirci Saadet E; Sahin U
J Cosmet Dermatol; 2023 Mar; 22(3):1077-1082. PubMed ID: 36437707
[TBL] [Abstract][Full Text] [Related]
16. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
Kutlu Ö
Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
[No Abstract] [Full Text] [Related]
17. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients.
Hareedy MS; Tawfik KM
J Cosmet Dermatol; 2022 Nov; 21(11):6191-6198. PubMed ID: 35770307
[TBL] [Abstract][Full Text] [Related]
18. Association Between Baseline Serum Lipids and Severity of Dry Eye Symptoms in Acne Patients Treated with Isotretinoin.
Alajaji AN
Cureus; 2024 May; 16(5):e60922. PubMed ID: 38910684
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Laboratory Follow-up in Acne Patients Treated With Isotretinoin.
Özaslan M; Peker D
Cutis; 2023 Jul; 112(1):38-43. PubMed ID: 37611311
[TBL] [Abstract][Full Text] [Related]
20. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.
Xia E; Han J; Faletsky A; Baldwin H; Beleznay K; Bettoli V; Dréno B; Goh CL; Stein Gold L; Gollnick H; Herane MI; Kang S; Kircik L; Mann J; Nast A; Oon HH; See JA; Tollefson M; Webster G; Zip C; Tan J; Tapper EB; Thiboutot D; Zaenglein A; Barbieri J; Mostaghimi A
JAMA Dermatol; 2022 Aug; 158(8):942-948. PubMed ID: 35704293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
